Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases

Vaccines are powerful tools for controlling microbial infections and preventing epidemic diseases. Efficient inactive, subunit, or viral-like particle vaccines usually rely on a safe and potent adjuvant to boost the immune response to the antigen. After a slow start, over the last decade there has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing-Xing, Tseng, Jen-Chih, Yu, Guann-Yi, Luo, Yunping, Huang, Chi-Ying F., Hong, Yi-Ren, Chuang, Tsung-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878135/
https://www.ncbi.nlm.nih.gov/pubmed/35214155
http://dx.doi.org/10.3390/pharmaceutics14020423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878135/
https://www.ncbi.nlm.nih.gov/pubmed/35214155
http://dx.doi.org/10.3390/pharmaceutics14020423

Ejemplares similares